Anavex Life Sciences Corp (AVXL)

[apostrophe]

re: "Book value is not a very relevant valuation method for young biotechs. BV is really for companies with a lot of physical capital (companies with heavy inventories (eg Best Buy), real estate (mall owners), financial assets (banks) or little goodwill or other balance sheet intangibles). "

Actually I agree. I would also add it as being somewhat useful in evaluating certain mining companies.

I suppose I was being a little tongue-in-cheek in response to a remembered criticism that appeared in a past negative article. i.e. Niether is it relevant to beat up on Anavex because it has a low BV.

The question is I guess is what sort of criteria is being applied? There haven't been any radical changes in fundamentals compared to the extent of some of the price action.

I don't believe I've used the word here but I also don't subscribe to the new definition of "conspiracy" as "something that doesn't exist". :)